SB85
Well-Known Member
Colorado voters approved an initiative on the ballot to legalize possession of certain psychedelics and create psilocybin “healing centers” on Tuesday.
Possession, use, cultivation and sharing of psilocybin, ibogaine, mescaline (not derived from peyote), DMT and psilocyn will be legalized for adults 21 and older, without an explicit possession limit. There will be no recreational sales component.
The Department of Regulatory Agencies will be responsible for developing rules for a therapeutic psychedelics program where adults 21 and older can visit a licensed healing center to receive treatment under the guidance of a trained facilitator.
There will be a two-tiered regulatory model, where only psilocybin and psilocyn will be permitted for therapeutic use at licensed healing centers until June 2026. After that point, regulators can decide whether to also permit regulated therapeutic use of DMT, ibogaine and mescaline.
A new 15-member Natural Medicine Advisory Board will be responsible for making recommendations on adding substances to the program, and the Department of Regulatory Agencies could then authorize those recommended additions.
The advisory board’s membership will specifically include people who have experience with psychedelic medicine in a scientific and religious context.
People who have completed their sentence for a conviction related to an offense made legal under the act will be able to petition the courts for record sealing. If there’s no objection from the district attorney, the court will need to automatically clear that record.
Colorado Voters Approve Psychedelics Legalization Ballot Initiative - Marijuana Moment
Possession, use, cultivation and sharing of psilocybin, ibogaine, mescaline (not derived from peyote), DMT and psilocyn will be legalized for adults 21 and older, without an explicit possession limit. There will be no recreational sales component.
The Department of Regulatory Agencies will be responsible for developing rules for a therapeutic psychedelics program where adults 21 and older can visit a licensed healing center to receive treatment under the guidance of a trained facilitator.
There will be a two-tiered regulatory model, where only psilocybin and psilocyn will be permitted for therapeutic use at licensed healing centers until June 2026. After that point, regulators can decide whether to also permit regulated therapeutic use of DMT, ibogaine and mescaline.
A new 15-member Natural Medicine Advisory Board will be responsible for making recommendations on adding substances to the program, and the Department of Regulatory Agencies could then authorize those recommended additions.
The advisory board’s membership will specifically include people who have experience with psychedelic medicine in a scientific and religious context.
People who have completed their sentence for a conviction related to an offense made legal under the act will be able to petition the courts for record sealing. If there’s no objection from the district attorney, the court will need to automatically clear that record.
Colorado Voters Approve Psychedelics Legalization Ballot Initiative - Marijuana Moment